333
Participants
Start Date
June 30, 2005
Study Completion Date
July 31, 2007
Mitomycin C; Capecitabine; Bevacizumab
Lismore Hospital, Lismore
Newcastle Mater Hospital, Newcastle
Bankstown Hospital, Sydney
Campbelltown Hospital, Sydney
Liverpool Hospital, Sydney
Nepean Hospital, Sydney
North Shore Private Hospital, Sydney
Prince of Wales Hospital, Sydney
Royal North Shore Hosp, Sydney
St George Hospital, Sydney
Sydney Cancer Centre, Concord Repat General Hospital, Sydney
Sydney Cancer Centre, Royal Prince Alfred Hospital, Sydney
Westmead Hospital, Sydney
Tamworth Base Hospital, Tamworth
Tweed Heads Hospital, Tweed Heads
Southern Medical Daycare, Wollongong
Royal Brisbane Hospital, Brisbane
Flinders Medical Centre, Adelaide
Queen Elizabeth Hospital / Lyell McEwin Centre, Adelaide
Royal Adelaide Hospital, Adelaide
Royal Hobart Hospital, Hobart
Bendigo Public Hospital, Bendigo
Geelong Hospital, Geelong
Austin Health, Melbourne
Box Hill Hospital, Melbourne
Frankston Hospital, Melbourne
Monash Medical Centre, Melbourne
Peter MacCallum Cancer Institute, Melbourne
St Vincent's Hospital, Melbourne
Border Medical Oncology, Wodonga
Fremantle Hospital, Perth
Royal Perth Hospital, Perth
Sir Charles Gairdner Hospital, Perth
St John of God Hospital, Subiaco, Perth
Christchurch Hospital, Christchurch
Palmerston North Hospital, Palmerston
Australasian Gastro-Intestinal Trials Group
NETWORK